Alan Cunningham - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alan Cunningham

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Nature Communications|March 2, 2022

The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemiaAyşegül Erdem, Silvia Marin, Diego A Pereira-Martins, et al.

Journal of Medicinal Chemistry|May 18, 2013

Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetesYulin Wu, Christopher J Aquino, David J Cowan, et al.

Blood|August 19, 2022

Dietary methionine starvation impairs acute myeloid leukemia progressionAlan Cunningham, Ayşegül Erdem, Islam Alshamleh, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Nature Communications|March 2, 2022

The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemiaAyşegül Erdem, Silvia Marin, Diego A Pereira-Martins, et al.

Journal of Medicinal Chemistry|May 18, 2013

Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetesYulin Wu, Christopher J Aquino, David J Cowan, et al.

Blood|August 19, 2022

Dietary methionine starvation impairs acute myeloid leukemia progressionAlan Cunningham, Ayşegül Erdem, Islam Alshamleh, et al.

Pageof 2